Bernard J Zovighian Edwards Lifesciences Corp (EW) insider trading activity

Bernard J Zovighian is CEO of Edwards Lifesciences Corp. Currently has a direct ownership of 80,976 shares of EW, which is worth approximately $5.98 Million. The most recent transaction as insider was on May 16, 2025, when has been sold 5,815 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 81K

37.06% 3M change

18.7% 12M change

Total Value Held $5.98 Million

Bernard J Zovighian Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 16 2025	SELL Bona fide gift	-	5,815 Reduced 6.7%	80,976 Common Stock
May 13 2025	SELL Bona fide gift	-	2,771 Reduced 3.09%	86,791 Common Stock
May 11 2025	SELL Payment of exercise price or tax liability	$210,724 $73.68 p/Share	2,860 Reduced 3.09%	89,562 Common Stock
May 08 2025	SELL Bona fide gift	-	4,122 Reduced 4.27%	92,422 Common Stock
May 08 2025	BUY Grant, award, or other acquisition	-	43,550 Added 31.09%	96,544 Common Stock
May 07 2025	SELL Payment of exercise price or tax liability	$318,634 $74.92 p/Share	4,253 Reduced 7.43%	52,994 Common Stock
May 06 2025	SELL Bona fide gift	-	1,036 Reduced 1.78%	57,247 Common Stock
May 05 2025	SELL Open market or private sale	$447,961 $74.91 p/Share	5,980 Reduced 9.31%	58,283 Common Stock
May 05 2025	SELL Bona fide gift	-	1,482 Reduced 2.25%	64,263 Common Stock
May 05 2025	BUY Exercise of conversion of derivative security	$337,879 $45.28 p/Share	7,462 Added 10.19%	65,745 Common Stock
May 04 2025	SELL Payment of exercise price or tax liability	$41,077 $75.65 p/Share	543 Reduced 0.92%	58,283 Common Stock
May 03 2025	SELL Payment of exercise price or tax liability	$39,867 $75.65 p/Share	527 Reduced 0.89%	58,826 Common Stock
Mar 10 2025	SELL Open market or private sale	$428,459 $69.51 p/Share	6,164 Reduced 9.45%	59,082 Common Stock
Mar 10 2025	SELL Bona fide gift	-	1,299 Reduced 1.95%	65,246 Common Stock
Mar 10 2025	BUY Exercise of conversion of derivative security	$337,924 $45.28 p/Share	7,463 Added 10.08%	66,545 Common Stock
May 30 2024	SELL Open market or private sale	$755,538 $87.68 p/Share	8,617 Reduced 11.22%	68,217 Common Stock
May 11 2024	SELL Payment of exercise price or tax liability	$247,498 $86.72 p/Share	2,854 Reduced 3.58%	76,834 Common Stock
May 07 2024	SELL Payment of exercise price or tax liability	$55,053 $85.09 p/Share	647 Reduced 0.81%	79,688 Common Stock
May 07 2024	BUY Grant, award, or other acquisition	-	33,500 Added 29.43%	80,335 Common Stock
May 04 2024	SELL Payment of exercise price or tax liability	$316,959 $85.25 p/Share	3,718 Reduced 7.35%	46,835 Common Stock
May 04 2024	BUY Exercise of conversion of derivative security	-	6,265 Added 11.03%	50,553 Common Stock
May 03 2024	SELL Payment of exercise price or tax liability	$44,826 $85.06 p/Share	527 Reduced 1.18%	44,288 Common Stock
Jul 31 2023	BUY Discretionary transaction	$213,695 $83.54 p/Share	2,558 Added 5.15%	47,111 Common Stock
May 11 2023	BUY Grant, award, or other acquisition	-	22,525 Added 33.58%	44,552 Common Stock
May 08 2023	SELL Payment of exercise price or tax liability	$127,164 $88.74 p/Share	1,433 Reduced 6.11%	22,027 Common Stock

BJZ

Bernard J Zovighian

CEO

Irvine, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EW shares.

Notify only if

Value

Insider Trading

Get notified when an Edwards Lifesciences Corp insider buys or sells EW shares.

Notify only if

Operation

Value

Type

News

Receive news related to Edwards Lifesciences Corp

Track Activities on EW

Account